Skip Navigation
Search Menu
Find an Expert

 


Una D McCann, M.D.

Photo of Dr. Una D McCann, M.D.

Associate Program Director JHBMC GCRC

Professor of Psychiatry and Behavioral Sciences

Female

Languages: English, Spanish

Expertise: Adult Psychiatry

Locations

Johns Hopkins Bayview Medical Center

4940 Eastern Avenue
Baltimore, MD 21224 map

Johns Hopkins Bayview Medical Center

5501 Hopkins Bayview Circle
Asthma and Allergy Center
Baltimore, MD 21224 map

The Johns Hopkins Hospital
Appointment Phone: 410-955-5104

600 N. Wolfe Street
Sheikh Zayed Tower
Baltimore, MD 21287 map

Background

Titles

  • Associate Program Director JHBMC GCRC
  • Director, Anxiety Disorders Program
  • Professor of Psychiatry and Behavioral Sciences
  • Professor of Neurology

Education

Degrees

  • MD, Duke University School of Medicine (1984)

Residencies

  • Stanford University School of Medicine / Psychiatry (1988)

Fellowships

  • Stanford University School of Medicine / Psychiatry (1988)

Board Certifications

  • American Board of Psychiatry & Neurology / Psychiatry (1990)
  • American Board of Psychiatry & Neurology / Psychosomatic Medicine (2008)

Research & Publications

Research Summary

My two active areas of research are in the areas of amphetamine-induced monoamine neurotoxicity (i.e., MDMA, Methamphetamine, ephedrine or amphetamine-induced monoaminergic neurotoxicity), and the neurobiology of anxiety disorders. Methods used in both research spheres include neuropharmacology, PET, MRI, fMRI, polysomnography, pharmacological challenge, and neuropsychiatric assessment. Studies of amphetamine neurotoxicity also include preclinical studies using microarrays, cell culture, rodents and primates.

Core Facility: Interdisciplinary Sleep, Research and Education (CISRE), Center for

Selected Publications

  1. McCann UD, Szabo Z, Scheffel U, Matthews WB, Dannals RF, Ravert HT, Musachio JL, Mertl MM, Ricaurte GA. Positron Emission Tomographic evidence of toxic effect of MDMA (AEcstasy@) on brain serotonin neurons in humans beings, The Lancet, 1998; 352:1433-1437.
  2. McCann UD, Wong DF, Villemagne V, Dannals RF, Ricaurte GA. Brain dopamine neurotoxicity in abstinent methamphetamine and methcathinone users: Evidence from PET studies with [11C]WIN- 35,428, Journal of Neuroscience 1998;18(20):8417-8422.
  3. McCann UD, Mertl MM, Eligulashvili V, Ricaurte GA. Cognitive performance in () 3,4- methylenedioxymethamphetamine (MDMA, "ecstasy") users: A controlled study, Psychopharmacology, 1999; 143:417-425
  4. McCann UD, Slate SO, Geraci M, Roscow-Terrill D, and Uhde TW. A comparison of the effects of intravenous pentagastrin in patients with social phobia, panic disorder, and healthy volunteers, Neuropsychopharmacology, 1997;16(3):229-237.
  5. Geraci M, Anderson TS, Slate-Cothren S, Post RM, McCann UD. Pentagastrin-induced sleep panic attacks: Panic in the absence of elevated baseline arousal. Biological Psychiatry, 2002;52(12):1183-9.

Videos & Media

Recent News Articles and Media Coverage

Hopkins Brain Wise Newsletter articles about Dr. McCann's work:

Translations: Model of a Muddle

Look What They’ve Done to Their Brains

Is this you? Edit Profile